Atlas Trials

I-Mab Biopharma US Limited

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch I-Mab Biopharma US Limited

RecordFirmDate
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) (NCT07432295)I-Mab Biopharma US Limited2026-02-11
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors (NCT04947033)I-Mab Biopharma US Limited2023-12-31
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors (NCT04900818)I-Mab Biopharma US Limited2021-06-29
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors (NCT04678921)I-Mab Biopharma US Limited2020-12-17
A Study of TJ003234 in Rheumatoid Arthritis Patients (NCT04457856)I-Mab Biopharma US Limited2020-08-06
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) (NCT04341116)I-Mab Biopharma US Limited2020-04-11
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma (NCT03934814)I-Mab Biopharma US Limited2019-04-16
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects (NCT03794180)I-Mab Biopharma US Limited2019-03-18

Track I-Mab Biopharma US Limited automatically

Every clearance here is in the API, with alerts when new ones post.